Alkylation of cysteine 468 in Stat3 defines a novel site for therapeutic development.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  ACS Chemical Biology

• Publication date

  2011-05-20

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1021/cb100253ePMID 21226522PMCID PMC3098940
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Modulation of gene expression and tumor cell growth by redox modification of STAT3.

  2010cited by this paper
• EGFR inhibitors in non-small cell lung cancer (NSCLC): the emerging role of the dual irreversible EGFR/HER2 inhibitor BIBW 2992

  2010cited by this paper
• Oncostatin M-induced and constitutive activation of the JAK2/STAT5/CIS pathway suppresses CCL1, but not CCL7 and CCL8 chemokine expression

  2009cited by this paper
• Molecular dynamics simulations of the conformational changes in signal transducers and activators of transcription, Stat1 and Stat3.

  2009cited by this paper
• Oncostatin M-Induced and Constitutive Activation of the JAK2/STAT5/CIS Pathway Suppresses CCL1, but Not CCL7 and CCL8, Chemokine Expression1

  2008cited by this paper
• Tyrosine phosphorylation regulates the partitioning of STAT1 between different dimer conformations

  2008cited by this paper
• BIBW2992, an irreversible EGFR/HER2 inhibitor highly effective in preclinical lung cancer models

  2008cited by this paper
• Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

  2007cited by this paper
• Nucleocytoplasmic shuttling of persistently activated STAT3

  2007cited by this paper
• Molecular basis for the aromatization reaction and exemestane-mediated irreversible inhibition of human aromatase.

  2007cited by this paper
• A Synthetic Triterpenoid, CDDO-Me, Inhibits IκBα Kinase and Enhances Apoptosis Induced by TNF and Chemotherapeutic Agents through Down-Regulation of Expression of Nuclear Factor κB–Regulated Gene Products in Human Leukemic Cells

  2006cited by this paper
• Triterpenoid CDDO-Me Blocks the NF-κB Pathway by Direct Inhibition of IKKβ on Cys-179*

  2006cited by this paper
• A synthetic triterpenoid, CDDO-Me, inhibits IkappaBalpha kinase and enhances apoptosis induced by TNF and chemotherapeutic agents through down-regulation of expression of nuclear factor kappaB-regulated gene products in human leukemic cells.

  2006cited by this paper
• Elevated Activity of STAT3C due to Higher DNA Binding Affinity of Phosphotyrosine Dimer Rather than Covalent Dimer Formation*

  2006cited by this paper
• Tyrosine phosphorylation is required for functional activation of disulfide-containing constitutively active STAT mutants.

  2006cited by this paper
• Triterpenoid CDDO-Me blocks the NF-kappaB pathway by direct inhibition of IKKbeta on Cys-179.

  2006cited by this paper
• Analysis of Stat3 (signal transducer and activator of transcription 3) dimerization by fluorescence resonance energy transfer in living cells.

  2004cited by this paper
• IRF-1 expression induces apoptosis and inhibits tumor growth in mouse mammary cancer cells in vitro and in vivo

  2004cited by this paper
• Real Time Analysis of STAT3 Nucleocytoplasmic Shuttling*

  2004cited by this paper
• The STATs of cancer — new molecular targets come of age

  2004cited by this paper
• STAT3 is enriched in nuclear bodies

  2004cited by this paper
• Inhibition of HER-kinase activation prevents ERK-mediated degradation of PPARgamma.

  2004cited by this paper
• Exemestane: a potent irreversible aromatase inactivator and a promising advance in breast cancer treatment

  2002cited by this paper
• Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention.

  2002cited by this paper
• Constitutive activation of Stat3 by the Src and JAK tyrosine kinases participates in growth regulation of human breast carcinoma cells

  2001cited by this paper
• STATs in oncogenesis

  2000cited by this paper
• The role of STATs in transcriptional control and their impact on cellular function

  2000cited by this paper
• Stat3 as an oncogene.

  1999cited by this paper
• Transcription factor activity of STAT proteins: structural requirements and regulation by phosphorylation and interacting proteins

  1999cited by this paper
• Three-dimensional structure of the Stat3β homodimer bound to DNA

  1998cited by this paper
• Epidermal growth factor-induced growth inhibition requires Stat1 activation.

  1998cited by this paper
• STATs and gene regulation.

  1997cited by this paper
• The structure, regulation and function of the Janus kinases (JAKs) and the signal transducers and activators of transcription (STATs).

  1997cited by this paper
• Preassociation of STAT1 with STAT2 and STAT3 in Separate Signalling Complexes Prior to Cytokine Stimulation (*)

  1996cited by this paper
• Transcriptionally active Stat1 is required for the antiproliferative effects of both interferon alpha and interferon gamma.

  1996cited by this paper
• Enhanced DNA-binding activity of a Stat3-related protein in cells transformed by the Src oncoprotein.

  1995cited by this paper
• Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins.

  1994cited by this paper
• The SIF binding element confers sis/PDGF inducibility onto the c‐fos promoter.

  1990cited by this paper
• Solvent-accessible surfaces of proteins and nucleic acids.

  1983cited by this paper

• Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery

  2024cites this paper
• Discovery of a 6-Aminobenzo[b]thiophene 1,1-Dioxide Derivative (K2071) with a Signal Transducer and Activator of Transcription 3 Inhibitory, Antimitotic, and Senotherapeutic Activities

  2024cites this paper
• Mechanistic Analysis of 5-Hydroxy γ-Pyrones as Michael Acceptor Prodrugs.

  2024cites this paper
• A New Renieramycin T Right-Half Analog as a Small Molecule Degrader of STAT3

  2024cites this paper
• The Multifaced Role of STAT3 in Cancer and Its Implication for Anticancer Therapy

  2021cites this paper
• Recent Update on Development of Small-Molecule STAT3 Inhibitors for Cancer Therapy: From Phosphorylation Inhibition to Protein Degradation.

  2021cites this paper
• Structure-Activity Study of Nitazoxanide Derivatives as Novel STAT3 Pathway Inhibitors.

  2021cites this paper
• Diagnostic and Treatment Methods for Ulcerative Colitis and Colitis-Associated Cancer

  2021cites this paper
• Natural STAT3 inhibitors: A mini perspective.

  2021cites this paper
• Drugging the 'undruggable'. therapeutic targeting of protein-DNA interactions with the use of computer-aided drug discovery methods.

  2021cites this paper
• The role of understudied post‐translational modifications for the behavior and function of Signal Transducer and Activator of Transcription 3

  2021cites this paper
• Towards the Inhibition of Protein–Protein Interactions (PPIs) in STAT3: Insights into a New Class of Benzothiadiazole Derivatives

  2020cites this paper
• STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy

  2020cites this paper
• Targeting STAT3 in Cancer Immunotherapy

  2020cites this paper
• Perspectives Regarding the Intersections between STAT3 and Oxidative Metabolism in Cancer

  2020cites this paper
• The garlic compound Z-ajoene, S-thiolates COX2 and STAT3 and dampens the inflammatory response in RAW264.7 macrophages.

  2020cites this paper
• STAT3 inhibitory activity of naphthoquinones isolated from Tabebuia avellanedae.

  2020cites this paper
• miR-124-3p regulates angiogenesis in peripheral arterial disease by targeting STAT3

  2020cites this paper
• 15-Keto prostaglandin E2 suppresses STAT3 signaling and inhibits breast cancer cell growth and progression

  2019cites this paper
• Revisiting the development of small molecular inhibitors that directly target the signal transducer and activator of transcription 3 (STAT3) domains.

  2019cites this paper
• Targeted inhibition of STAT3 as a potential treatment strategy for atherosclerosis

  2019cites this paper
• Discovery of a New STAT3 Inhibitor Acting on the Linker Domain.

  2019cites this paper
• Revisiting signal transducer and activator of transcription 3 (STAT3) as an anticancer target and its inhibitor discovery: Where are we and where should we go?

  2019cites this paper
• Signal Transducer and Activator of Transcription Protein 3 (STAT3): an Update on its Direct Inhibitors as Promising Anticancer Agents.

  2019cites this paper
• Curcumin interacts directly with the Cysteine 259 residue of STAT3 and induces apoptosis in H-Ras transformed human mammary epithelial cells

  2018cites this paper
• Targeting Transcription Factors for Cancer Treatment

  2018cites this paper
• STAT3: a multifaceted oncoprotein

  2018cites this paper
• Targeted inhibition of STAT/TET1 axis as a therapeutic strategy for acute myeloid leukemia

  2017cites this paper
• Inhibition of STAT3 by Anticancer Drug Bendamustine

  2017cites this paper
• Role of STAT3 N-terminal domain and GAS-site recognition in signaling and crosstalk with STAT1 and NF-κB

  2017influential citation
• Evaluation of quantitative assays for the identification of direct signal transducer and activator of transcription 3 (STAT3) inhibitors

  2016cites this paper
• Preclinical Characterization of 3β-(N-Acetyl l-cysteine methyl ester)-2aβ,3-dihydrogaliellalactone (GPA512), a Prodrug of a Direct STAT3 Inhibitor for the Treatment of Prostate Cancer.

  2016cites this paper
• Dissecting functions of the N-terminal domain and GAS-site recognition in STAT3 nuclear trafficking.

  2016cites this paper
• Allosteric Communication across STAT3 Domains Associated with STAT3 Function and Disease-Causing Mutation.

  2016cites this paper
• Mitochondrial STAT3: Powering up a potent factor.

  2016cites this paper
• STAT3 Inhibitors in Cancer: A Comprehensive Update

  2016cites this paper
• Chapter 5 STAT 3 Inhibitors in Cancer : A Comprehensive Update

  2016cites this paper
• The immunomodulatory effects of the garlic organosulfur compounds allicin and Z-ajoene in an in vitro murine model of LPS-induced inflammation

  2015cites this paper
• Eriocalyxin B Inhibits STAT3 Signaling by Covalently Targeting STAT3 and Blocking Phosphorylation and Activation of STAT3

  2015cites this paper
• Targeting Transcription Factor Binding to DNA by Competing with DNA Binders as an Approach for Controlling Gene Expression.

  2015cites this paper
• Crispene E, a cis-clerodane diterpene inhibits STAT3 dimerization in breast cancer cells.

  2015cites this paper
• Developing Inhibitors of STAT3: Targeting Downstream of the Kinases for Treating Disease

  2015cites this paper
• Novel aminotetrazole derivatives as selective STAT3 non-peptide inhibitors.

  2015cites this paper
• Computational Method To Identify Druggable Binding Sites That Target Protein-Protein Interactions

  2014cites this paper
• A Small Molecule Compound Targeting STAT3 DNA-Binding Domain Inhibits Cancer Cell Proliferation, Migration, and Invasion

  2014cites this paper
• Cancer Cells Transcription Factor STAT 3 in Prostate Galiellalactone Is a Direct Inhibitor of the Signal Transduction

  2014cites this paper
• Galiellalactone Is a Direct Inhibitor of the Transcription Factor STAT3 in Prostate Cancer Cells*♦

  2014cites this paper
• Identification of novel inhibitors that disrupt STAT3-DNA interaction from a γ-AApeptide OBOC combinatorial library.

  2014cites this paper
• Small molecule compounds targeting DNA binding domain of STAT3 for inhibition of tumor growth and metastasis

  2014influential citation
• Targeting Mitochondrial STAT3 with the Novel Phospho-Valproic Acid (MDC-1112) Inhibits Pancreatic Cancer Growth in Mice

  2013cites this paper
• CRM1 Is a Cellular Target of Curcumin: New Insights for the Myriad of Biological Effects of an Ancient Spice

  2013influential citation
• Diallyl trisulfide suppresses dextran sodium sulfate-induced mouse colitis: NF-κB and STAT3 as potential targets.

  2013cites this paper
• Epothilone D and its 9-Methyl analogues: combinatorial syntheses, conformation, and biological activities.

  2013cites this paper
• Investigation of the protein alkylation sites of the STAT3:STAT3 inhibitor Stattic by mass spectrometry.

  2013cites this paper
• Identification of Cys255 in HIF‐1α as a novel site for development of covalent inhibitors of HIF‐1α/ARNT PasB domain protein–protein interaction

  2012cites this paper
• Large granular lymphocyte leukemia: from dysregulated pathways to therapeutic targets.

  2012cites this paper
• Factors That Affect the Computational Prediction of Hot Spots in Protein-Protein Complexes

  2012cites this paper
• Individual Interferon Regulatory Factor-3 Thiol Residues Are Not Critical for Its Activation Following Virus Infection

  2012cites this paper
• Synthesis of Triazole‐Epothilones by Using Cu2O Nanoparticles to Catalyze 1,3‐Dipolar Cycloaddition

  2012cites this paper